| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-angiogenesis: making the tumor vulnerable to the immune system
|
Griffioen, Arjan W.
|
|
2008
|
57 |
10 |
p. 1553-1558
|
artikel
|
| 2 |
Combined modality immunotherapy and chemotherapy: a new perspective
|
Ramakrishnan, Rupal
|
|
2008
|
57 |
10 |
p. 1523-1529
|
artikel
|
| 3 |
Dendritic cell vaccination and immune monitoring
|
Aarntzen, E. H. J. G.
|
|
2008
|
57 |
10 |
p. 1559-1568
|
artikel
|
| 4 |
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma
|
Goldstein, Oliver G.
|
|
2008
|
57 |
10 |
p. 1461-1470
|
artikel
|
| 5 |
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells
|
Grünebach, Frank
|
|
2008
|
57 |
10 |
p. 1483-1491
|
artikel
|
| 6 |
IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma
|
Frederiksen, Klaus Stensgaard
|
|
2008
|
57 |
10 |
p. 1439-1449
|
artikel
|
| 7 |
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis
|
Thornton, Lisa M.
|
|
2008
|
57 |
10 |
p. 1471-1481
|
artikel
|
| 8 |
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
|
Tsuji, Kazuhide
|
|
2008
|
57 |
10 |
p. 1429-1437
|
artikel
|
| 9 |
Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
|
Srivastava, Minu K.
|
|
2008
|
57 |
10 |
p. 1493-1504
|
artikel
|
| 10 |
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
|
Malmberg, Karl-Johan
|
|
2008
|
57 |
10 |
p. 1541-1552
|
artikel
|
| 11 |
Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?
|
Visser, Karin E. de
|
|
2008
|
57 |
10 |
p. 1531-1539
|
artikel
|
| 12 |
The E75 HER2/neu peptide vaccine
|
Mittendorf, Elizabeth A.
|
|
2008
|
57 |
10 |
p. 1511-1521
|
artikel
|
| 13 |
The E75 HER2/neu peptide vaccine
|
Mittendorf, Elizabeth A.
|
|
|
57 |
10 |
p. 1511-1521
|
artikel
|
| 14 |
Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15–17 November 2007
|
Pawelec, Graham
|
|
2008
|
57 |
10 |
p. 1505-1509
|
artikel
|
| 15 |
Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15–17 November 2007
|
Pawelec, Graham
|
|
|
57 |
10 |
p. 1505-1509
|
artikel
|
| 16 |
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
|
Gruijl, Tanja D. de
|
|
2008
|
57 |
10 |
p. 1569-1577
|
artikel
|
| 17 |
Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages
|
Tsagozis, Panagiotis
|
|
2008
|
57 |
10 |
p. 1451-1459
|
artikel
|
Tijdschrift beschrijving